Why Deal Inspections Don’t Work and What Actually Moves Deals Forward

Too many deal inspections become interrogations.

What’s missing?
Why don’t we know that?
Have you talked to the decision-maker?
Why hasn’t this happened?
Is this really going to close?

The manager wants visibility. The seller feels pressure to defend the deal. Everyone leaves with a longer list of things that are wrong.

The deal may have been inspected. But was it actually improved?

That distinction matters.

Because identifying what’s wrong with a deal is not the same as knowing what to do next.

The Problem With Traditional Deal Inspections

Early in my sales leadership career, I ran deal inspection calls.

I introduced a simple one-page Deal Sheet and asked sales professionals to document their top opportunities in a structured format.

The goal wasn’t activity tracking.

I wanted to understand:

• How well was the deal actually qualified?
• What did the customer really need?
• Who mattered in the decision?
• Where were the risks?
• What was missing?
• What would it take to win?

For some people, it worked extremely well.

For others, it didn’t.

And a pattern started to emerge.

The people who resisted the inspection often struggled to answer the most important questions about their deals.

The opportunity might exist in the CRM.

There might be meetings.

There might be a proposal.

There might even be a confident forecast.

But underneath the activity, the deal was thin.

Over time, the consequences became obvious:

• Deals stalled
• Close dates slipped
• Pipeline momentum slowed
• Forecast confidence dropped
• Opportunities that looked healthy disappeared

That led to a much more important question:

What’s really going on inside these deals?

We Stopped Inspecting Deals and Started Feeding Them

Eventually, we changed the approach.

We called the new sessions:

Deal Nutrition Calls

The idea was simple.

Instead of bringing a deal into a meeting to defend it, bring the deal in to make it better.

Sales professionals brought opportunities that were stuck, at risk, or losing momentum.

The conversation changed.

Instead of:

What’s wrong with this deal?

we asked:

What needs to happen next to improve our chances of winning it?

That changed everything.

Why Deal Nutrition Worked

The difference wasn’t the meeting format.

It was the purpose.

From inspection to improvement.

From judgment to collaboration.

From identifying gaps to figuring out how to close them.

The conversation became less about defending the past and more about influencing the future.

People engaged.

Problems surfaced earlier.

Strategies got stronger.

Next steps became clearer.

And we gained a much better understanding of which deals were actually moving and which ones only looked busy.

Activity Is Not Progress

This is one of the most important lessons in complex B2B sales.

A busy deal is not necessarily a healthy deal.

Six customer meetings do not prove the customer is going to buy.

A proposal does not prove there is executive sponsorship.

A late CRM stage does not prove the opportunity is properly qualified.

A scheduled follow-up does not prove the buyer is committed to moving forward.

And a seller saying, “I feel good about this one,” is not buyer evidence.

Seller activity measures what the sales team is doing. Deal progress measures what the buyer is doing.

Those are very different things.

What Most Deal Reviews Miss

Traditional deal reviews tend to stop after identifying the problem.

No economic buyer.

Weak business case.

Unclear decision process.

Missing champion.

Unknown competition.

No mutual plan.

Those observations may all be correct.

But then what?

Knowing that a deal has a problem does not advance the deal.

The real value comes from determining:

• Why does the gap matter?
• How serious is the risk?
• What could it do to the deal?
• What should we do about it?
• Who should take action?
• What should happen next?

That is where inspection becomes advancement.

A Better Way to Inspect a Deal

A productive deal inspection should accomplish four things.

1. Establish What’s Real

Start with evidence, not optimism.

What do we actually know?

What has the buyer confirmed?

What are we assuming?

Where is the evidence strong?

Where is it thin or contradictory?

The purpose is not to prove the deal is bad.

The purpose is to understand its actual condition.

2. Find What Matters

Not every unanswered question is equally important.

A missing contact title might be administrative.

No access to the economic buyer on a major late-stage opportunity could be critical.

A strong inspection separates ordinary missing information from the issues that could actually change the outcome of the deal.

3. Understand Why It Matters

Finding a gap is only the beginning.

If executive sponsorship is weak, what does that mean for the deal?

If the business value hasn’t been validated, what happens when procurement challenges the price?

If the decision process is unclear, how defensible is the close date?

Risk becomes useful when you understand its consequence.

4. Turn Insight Into Action

Every meaningful finding should lead somewhere.

What conversation needs to happen?

Who needs to be engaged?

What evidence needs to be validated?

What objection needs to be resolved?

What commitment should we seek from the buyer?

What is the next best move?

Inspection should end with action, not a list of deficiencies.

This Is Why We Built Nello™

Years later, the thinking behind those Deal Nutrition Calls became part of the foundation for Deal Health-AI™ with Nello™.

The technology is different.

The principle isn’t.

Don’t just inspect the deal. Make the deal better.

Inspector Nello™ examines the opportunity, the CRM data, available deal evidence, seller knowledge, stakeholder dynamics, buyer commitments, risks, and qualification strength.

Nello works to determine:

• What’s strong
• What’s missing
• What’s at risk
• What could derail the opportunity
• What needs to happen next

The resulting Deal Health-MRI™ provides a diagnostic view of the opportunity, including qualification, integrity signals, forecast assessment, strengths, gaps, risks, workplans, and next best actions.

But Nello doesn’t stop at the diagnosis.

That is where the original idea behind Deal Nutrition becomes even more important.

From Inspector to Advisor and Coach

Once Nello understands the condition of the opportunity, the conversation can move from:

“Here’s the problem.”

to:

“Let’s work the problem.”

Advisor Nello™ can challenge assumptions, explore strategy, work through obstacles, and develop actions to strengthen the opportunity.

Coach Nello™ can prepare the sales professional for an executive meeting, discovery conversation, presentation, business case discussion, procurement negotiation, or another critical moment in the deal.

Nello’s Win Room™ can go deeper into competition, win themes, executive sponsorship, business value, and the path to win.

The cycle becomes:

Inspect → Diagnose → Strategize → Execute

That is a very different objective from running another weekly pipeline review.

The Bottom Line

I still believe in deal inspection.

I just don’t believe inspection is enough.

You need to know what’s real.

You need to know what’s missing.

You need to understand what could derail the opportunity.

But most importantly:

You need to know what to do next.

That was the idea behind Deal Nutrition years ago.

Today, it is central to what we are building with Deal Health-AI™ and Nello™.

Stop inspecting deals just to find what’s wrong.

Inspect them to figure out how to win.

Neil Colstad
Founder & CEO, Prescriptas